• Technical Guide: YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-y

  2026-05-25

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol enables targeted inhibition of hypoxia-inducible factor 1 transcriptional activity and modulation of soluble guanylyl cyclase in preclinical cancer and vascular biology research. It is unsuitable for diagnostic or therapeutic use and should be handled according to its specific solubility and storage parameters to ensure reproducibility.

• c-Myc tag Peptide: Precision Modulation in Advanced Transcri

  2026-05-25

  Explore how the c-Myc tag Peptide advances transcription factor research and immunoassay innovation. This article uniquely bridges molecular displacement mechanisms with emerging insights from selective autophagy, offering assay designers a deeper, actionable perspective.

• TAI-1: Reliable Hec1 Inhibition for Advanced Cancer Assays

  2026-05-24

  This article guides biomedical researchers through practical laboratory challenges in cell viability, proliferation, and cytotoxicity assays, highlighting how TAI-1 (SKU B4892) offers reproducible, data-backed solutions. Drawing on scenario-driven Q&A and recent literature, it demonstrates the scientific advantages of TAI-1 as a potent Hec1 inhibitor for robust cancer research workflows.

• NMDA Modeling: Next-Gen Strategies for Retinal Degeneration

  2026-05-23

  Explore how NMDA (N-Methyl-D-aspartic acid) is transforming translational research on retinal neurodegeneration and ferroptosis. This article delivers mechanistic clarity, strategic protocol guidance, and competitive insight for researchers modeling excitotoxicity and oxidative stress, with direct links to clinical innovation.

• CGP 55845 Hydrochloride: GABAB Antagonist in Synaptic Resear

  2026-05-22

  CGP 55845 hydrochloride stands out as a potent, selective GABAB receptor antagonist, enabling precise modulation of neurotransmitter release in advanced in vitro workflows. Its high affinity and robust antagonism empower researchers to dissect astrocyte-neuron interactions and synaptic transmission mechanisms with unrivaled specificity.

• Nirmatrelvir (PF-07321332): Precision Targeting of SARS-CoV-

  2026-05-22

  Explore how Nirmatrelvir (PF-07321332) enables advanced, mechanism-driven SARS-CoV-2 replication inhibition for antiviral therapeutics research. This article uniquely dissects molecular selectivity, assay design, and translational insights for COVID-19 studies.

• TRPV1 and TAS2R38 Modulation Alleviates GERD: Mechanisms Unv

  2026-05-21

  This study reveals that combined berberine and evodiamine therapy reduces gastroesophageal reflux disease (GERD) pathology via coordinated regulation of TAS2R38 and TRPV1, impacting MAPK/NF-κB signaling and macrophage polarization. These mechanistic insights highlight new directions for targeting sensory neuron pathways and epithelial integrity in GERD.

• PKH26 Red Fluorescent Cell Linker Kit: Technical Workflow Gu

  2026-05-21

  The PKH26 Red Fluorescent Cell Linker Kit enables stable and minimally toxic labeling of the cell membrane lipid region for long-term cell tracing and proliferation tracking. It is optimized for in vitro and in vivo studies that require persistent, membrane-specific fluorescence, but should not be used for intracellular or non-membrane labeling applications.

• Dynamic Expansion of Atrial Slow Conduction in Persistent AF

  2026-05-20

  Lange et al. reveal that regions of atrial slow conduction enlarge, rather than multiply, during premature stimulation in persistent atrial fibrillation (AF) animal models. This dynamic remodeling advances mechanistic understanding of arrhythmogenic substrates and informs the design of targeted therapies or mechanistic studies on atrial conduction.

• FOLR3 Amplifies TGFβ Signaling and Drives Fibrosis in NASH

  2026-05-20

  The referenced study uncovers secreted folate receptor gamma (FOLR3) as a key amplifier of TGFβ signaling in hepatic stellate cells, advancing fibrogenesis in nonalcoholic steatohepatitis (NASH). This mechanistic insight not only identifies FOLR3 as a potential therapeutic target but also provides a robust experimental framework for studying fibrosis-specific protein interactions, with implications for translational liver disease research.

• Levofloxacin in Research: Protocols and Assay Optimization G

  2026-05-19

  Levofloxacin is a synthetic fluoroquinolone antibiotic uniquely suited for dissecting bacterial DNA replication, bone metabolism, and cartilage biochemistry in preclinical research. Discover how to optimize workflows, troubleshoot common pitfalls, and leverage APExBIO’s Levofloxacin for robust, reproducible results across antibacterial and cell-based assays.

• DMH1: Precision ALK2 Inhibitor for Organoid & NSCLC Research

  2026-05-19

  DMH1 stands out as a highly selective ALK2 inhibitor, empowering researchers to precisely dissect BMP signaling in organoid and non-small cell lung cancer workflows. Its robust, well-characterized performance profile enables high-fidelity control of cell fate, proliferation, and differentiation in both advanced disease models and tissue engineering platforms.

• Fosinopril Sodium: Optimizing ACE Inhibitor Workflows in Hyp

  2026-05-18

  Fosinopril sodium from APExBIO stands out as a robust ACE inhibitor, enabling precision in hypertension and cardiovascular disease models. This guide delivers actionable workflow enhancements, troubleshooting strategies, and protocol parameters for reproducible blood pressure and renal hemodynamics studies.

• Acifran: Structural Insights for Precision Lipid Metabolism

  2026-05-18

  Explore how Acifran, a selective HM74A/GPR109A agonist, advances lipid metabolism research through structural insights and protocol optimization. This article uniquely connects cryo-EM discoveries to practical assay design for metabolic disorder studies.

• (+)-Bicuculline: Technical Use and Protocol Parameters

  2026-05-17

  (+)-Bicuculline is applied in neuroscience research to selectively antagonize GABAA receptors and probe GABAergic signaling pathways. It is not for diagnostic or clinical applications and demands rigorous attention to solubility and storage for reproducible experimental outcomes.

15777 records 1/1052 page Next 12345 下5页 Last page